青少年月经周期模式、体质指数、多囊卵巢综合征的内分泌与卵巢超声特征及未来生育力、心血管与代谢健康:一项25年纵向随访研究
基于POMP研究对160名女性随访25年,青少年期月经过稀者接受助孕治疗更多,但活产率与月经规律者相当;持续月经过稀可能与心血管或代谢问题相关。成人BMI、妊娠期高血压或子痫前期风险两组相当,持续月经过稀组心血管与代谢问题合并患病率为14%,月经规律组为7%。
要点
- 青少年月经过稀者接受助孕治疗更多,但活产率与月经规律者相当。
- 持续月经过稀者心血管与代谢问题合并患病率为14%,月经规律者为7%。
- 青少年月经过稀者成年后心血管或代谢问题可能与持续月经过稀相关。
核心结论
- 青少年月经过稀者接受助孕治疗更多,但活产率与月经规律者相当;持续月经过稀可能与心血管或代谢问题相关。
研究设计与样本
- 基于1990至1997年间开展的以人群为基础的青少年月经异常研究(POMP研究)的25年前瞻性随访研究,271名受邀成人中160名(59%)参与。
- 160名受试者完成问卷,青少年期平均年龄15.3岁,随访时平均年龄39.6岁;108名青少年期月经规律,52名月经过稀。
主要发现
- 青少年期月经规律者中12人从未尝试怀孕,4人尝试但未怀孕,96人中92人(96%)怀孕,96人中89人(93%)至少分娩一个活产儿,中位子女数为2。
- 青少年期月经规律者平均受孕时间(TTP)为8.4个月,月经过稀者为13.2个月(P=0.08);不孕分别为18%和26%。
- 52名青少年期月经过稀者中47人尝试怀孕,45人成功获得至少一个活产。
- 28%的受试者报告月经模式随时间变化;青少年期月经过稀者中50%转为规律周期,月经规律者中16%转为月经过稀,后者报告的不孕显著更多(40%,P=0.04)。
- 持续月经过稀者中显著比例(40%)接受生育治疗(P=0.04);成人BMI两组无差异;妊娠期高血压或子痫前期风险两组相当;持续月经过稀组心血管与代谢问题合并患病率为14%,青少年期月经规律组为7%。
临床怎么用
- 作者认为,青少年月经过稀者可被告知,其活产机会与月经周期规律者相当。
局限性
- 研究样本量小。
- 青少年月经过稀者与月经规律者至少一个活产儿比例差异小,令人欣慰。
- 受孕时间数据可能因月经过稀成人早期治疗而产生偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the predictive value of oligomenorrhea and other PCOS diagnostic characteristics in adolescence (age 15-18 years) for future fertility and cardiovascular and metabolic health at adult age? SUMMARY ANSWER: Adolescents with oligomenorrhea are more often treated to conceive but are as likely to have as much children as those with regular periods, while persisting oligomenorrhea may associate more often with cardiovascular or metabolic problems. WHAT IS KNOWN ALREADY: Adolescents with oligomenorrhea have a high risk for adult PCOS associated with subfertility due to ovulatory disorders and long-term health risks. Longitudinal studies to estimate the extent of these risks with input starting at adolescence and covering the complete reproductive lifespan are lacking. STUDY DESIGN, SIZE, DURATION: A 25-year prospective follow-up study based on a unique population-based adolescent study on menstrual irregularities performed between 1990 and 1997, the Pubertal Onset of Menstrual Cycle abnormalities, a Prospective study (POMP study). Of the 271 invited adults, 160 (59%) participated. PARTICIPANTS/MATERIALS, SETTING, METHODS: We contacted stratified samples of the POMP study cohort two decades after the initial study for a questionnaire assessing PCOS features, fertility history, pregnancy outcome, metabolic, and cardiovascular health. One hundred and sixty subjects completed the questionnaire. The mean adolescent age was 15.3 years, and the women were 39.6 years at the time of follow-up. One hundred and eight subjects had a regular menstrual cycle as adolescents and 52 were oligomenorrheic. MAIN RESULTS AND THE ROLE OF CHANCE: Of those with adolescent regular menstrual cycles 12 never tried to conceive, 4 tried but never conceived and 92 of 96 (96%) conceived, 89 of 96 (93%) delivering at least one living child. The median number of children was two. The mean time to pregnancy (TTP) was 8.4 months in the women with regular periods as adolescents and 13.2 months in case of oligomenorrhea (P = 0.08) and subfertility was present in respectively 18% and 26%. 47 of 52 adolescents with oligomenorrhea tried to conceive and 45 succeeded to have at least one live birth. Twenty-eight per cent of the subjects reported a change over time of their menstruation pattern. Fifty per cent of the girls with adolescent oligomenorrhea developed a regular cycle and 16% of those with regular periods changed to oligomenorrhea with significantly more reported subfertility (40%, P = 0.04). In case of persistent oligomenorrhea, a significant proportion (40%) underwent fertility treatment (P = 0.04). Adult BMI did not differ between groups. The risk for pregnancy-induced hypertension or pre-eclampsia was comparable between the groups. Gestational diabetes developed in three subjects each with persistent oligo amenorrhea. Adult diabetes, hypertension, and hypercholesterolemia were also mostly reported in case of persistent oligomenorrhea. In this group, the prevalence of combined cardiovascular and metabolic problems was 14% compared to 7% in the case of regular menstrual cycles as adolescent. LIMITATIONS, REASONS FOR CAUTION: The numbers in the study are small. However, the small difference between the percentage with a least one living child of those with adolescent oligomenorrhea versus those with adolescent regular menstrual cycles is reassuring. Time to pregnancy data may have been biased by early treatment of oligomenorrheic adults. WIDER IMPLICATIONS OF THE FINDINGS: Oligomenorrheic adolescents may be reassured that their chance to have a live birth is comparable with those with a regular menstrual cycle. STUDY FUNDING/COMPETING INTEREST(S): This research received no external funding, J.S.E.L. received unrestricted research grants from the following companies (in alphabetical order): Ansh Labs, Ferring, Merck, and Roche Diagnostics. He received consultancy fees or royalties from Ansh Labs, Art pred, Ferring, Gedeon Richter, and Roche Diagnostics. He received presentation fees from Ferring and Roche Diagnostics as well as support for attending meetings and/or travel from Ferring and Roche Diagnostics and he participated in the advisory board of the LOCI Trial UK. TRIAL REGISTRATION NUMBER: Dutch Trial Registry, NTR5871.
引用
- van Hooff MHA, Caanen MR, Peters HE, et al. Adolescent menstrual cycle pattern, body mass index, endocrine and ovarian ultrasound characteristics of PCOS and future fertility, cardiovascular-, and metabolic health: a 25-year longitudinal follow-up study. Hum Reprod. 2025. PMID: 39656822. doi:10.1093/humrep/deae262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。